Craig I. Campbell

551 total citations
18 papers, 458 citations indexed

About

Craig I. Campbell is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Craig I. Campbell has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Craig I. Campbell's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Cancer Cells and Metastasis (5 papers) and Metabolism, Diabetes, and Cancer (3 papers). Craig I. Campbell is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Cancer Cells and Metastasis (5 papers) and Metabolism, Diabetes, and Cancer (3 papers). Craig I. Campbell collaborates with scholars based in Canada, United Kingdom and United States. Craig I. Campbell's co-authors include Roger A. Moorehead, Jim Petrik, Robert A. Jones, Rama Khokha, Lewis A. Chodosh, Edward J. Gunther, Geoffrey A. Wood, Melissa H. Brown, Heather McGowan and R. Stout and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Craig I. Campbell

18 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig I. Campbell Canada 11 297 251 146 134 38 18 458
Golareh Habibi Canada 5 430 1.4× 241 1.0× 151 1.0× 150 1.1× 45 1.2× 7 582
Zhefu Ma United States 12 551 1.9× 251 1.0× 145 1.0× 88 0.7× 45 1.2× 12 634
Robert Cozens Switzerland 2 330 1.1× 142 0.6× 126 0.9× 228 1.7× 56 1.5× 3 475
Boris Freydin United States 10 241 0.8× 274 1.1× 117 0.8× 58 0.4× 34 0.9× 17 470
Dao Doan United States 7 250 0.8× 179 0.7× 67 0.5× 117 0.9× 71 1.9× 11 437
Xiukun Hou China 10 297 1.0× 150 0.6× 139 1.0× 90 0.7× 83 2.2× 26 483
Rana Abdel‐Fattah United States 10 212 0.7× 80 0.3× 108 0.7× 111 0.8× 23 0.6× 11 421
Tao Hai China 12 314 1.1× 107 0.4× 234 1.6× 94 0.7× 35 0.9× 17 523
Shannon L. Gibson United States 7 426 1.4× 238 0.9× 194 1.3× 50 0.4× 43 1.1× 8 548
Mariangela Balistreri Italy 10 270 0.9× 124 0.5× 219 1.5× 67 0.5× 89 2.3× 15 487

Countries citing papers authored by Craig I. Campbell

Since Specialization
Citations

This map shows the geographic impact of Craig I. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig I. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig I. Campbell more than expected).

Fields of papers citing papers by Craig I. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig I. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig I. Campbell. The network helps show where Craig I. Campbell may publish in the future.

Co-authorship network of co-authors of Craig I. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Craig I. Campbell. A scholar is included among the top collaborators of Craig I. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig I. Campbell. Craig I. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Trelford, Charles B., Evelyn Ng, Craig I. Campbell, & Gianni M. Di Guglielmo. (2021). p62/Sequestosome 1 regulates transforming growth factor beta signaling and epithelial to mesenchymal transition in A549 cells. Cellular Signalling. 85. 110040–110040. 2 indexed citations
2.
Lee, Sang‐Hyun, et al.. (2020). SMURF2 and SMAD7 induce SARA degradation via the proteasome. Cellular Signalling. 72. 109627–109627. 5 indexed citations
3.
Glasspool, Rosalind, Sarah P. Blagden, Michelle Lockley, et al.. (2017). A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.. Journal of Clinical Oncology. 35(15_suppl). 2594–2594. 3 indexed citations
4.
Campbell, Craig I., Payman Samavarchi‐Tehrani, Miriam Barrios‐Rodiles, et al.. (2016). The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin. Journal of Cell Science. 129(18). 3396–3411. 27 indexed citations
5.
Jones, Robert A., Katrina L. Watson, Craig I. Campbell, & Roger A. Moorehead. (2014). IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development. PLoS ONE. 9(9). e108781–e108781. 4 indexed citations
6.
Campbell, Craig I., et al.. (2011). Murine mammary tumor cells with a claudin-low genotype. Cancer Cell International. 11(1). 28–28. 11 indexed citations
7.
8.
9.
Campbell, Craig I., Jim Petrik, & Roger A. Moorehead. (2010). ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis. Molecular Cancer. 9(1). 235–235. 10 indexed citations
10.
Jones, Robert A., Craig I. Campbell, Geoffrey A. Wood, Jim Petrik, & Roger A. Moorehead. (2009). Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene. 28(21). 2152–2162. 47 indexed citations
11.
Campbell, Craig I., et al.. (2009). Type I Insulin-like Growth Factor Receptor Induces Pulmonary Tumorigenesis. Neoplasia. 11(7). 672–682. 17 indexed citations
12.
Jones, Robert A., Craig I. Campbell, Jim Petrik, & Roger A. Moorehead. (2008). Characterization of a Novel Primary Mammary Tumor Cell Line Reveals that Cyclin D1 Is Regulated by the Type I Insulin-Like Growth Factor Receptor. Molecular Cancer Research. 6(5). 819–828. 17 indexed citations
13.
Jones, Robert A., Craig I. Campbell, Edward J. Gunther, et al.. (2006). Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene. 26(11). 1636–1644. 108 indexed citations
14.
Campbell, Craig I., et al.. (2005). IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells. Oncogene. 24(49). 7310–7319. 49 indexed citations
15.
Gelmon, Karen A., Anthony W. Tolcher, Séamus O’Reilly, et al.. (1998). A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer. Annals of Oncology. 9(11). 1247–1249. 9 indexed citations
16.
Gelmon, Karen A., Sean OʼReilly, Anthony W. Tolcher, et al.. (1996). Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.. Journal of Clinical Oncology. 14(4). 1185–1191. 54 indexed citations
17.
Thatcher, Nicholas, Michael Lind, R. Stout, et al.. (1989). Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus. British Journal of Cancer. 60(1). 98–101. 44 indexed citations
18.
Campbell, Craig I., Tetjana Ross, & Frances J. Sharom. (1983). Functional reassembly of lymphocyte lentil lectin receptor glycoproteins into lipid bilayer vesicles. Biochimica et Biophysica Acta (BBA) - Biomembranes. 730(1). 95–103. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Golareh Habibi Breakdown of academic impact, for papers by Zhefu Ma Breakdown of academic impact, for papers by Robert Cozens Breakdown of academic impact, for papers by Boris Freydin Breakdown of academic impact, for papers by Dao Doan Breakdown of academic impact, for papers by Xiukun Hou Breakdown of academic impact, for papers by Rana Abdel‐Fattah Breakdown of academic impact, for papers by Tao Hai Breakdown of academic impact, for papers by Shannon L. Gibson Breakdown of academic impact, for papers by Mariangela Balistreri
Rankless by CCL
2026